Sun Pharma
The Sensex and the Nifty plunged nearly 1.4 percent at the closing session as investors turned wary ahead of the Federal Reserve two-day policy meeting. Investors braced for a possible hawkish shift in the Federal Reserve’s policy stance in the lead-up to the US central bank’s two-day policy meeting later in the day. The 30-share [...] Continue Reading »
A lot of new companies are entering the Fortune magazine list. Tobacco-to-FMCG conglomerate ITC has replaced Tata group IT giant TCS as the country’s most admired company on a Fortune magazine list. This list has got as many as 19 new entrants including Cognizant, Birla group firm Idea Cellular and discom BSES Rajdhani Power Ltd. [...] Continue Reading »
Due to the advent of the Narendra Modi government, there has been a heightened activity and business optimism in the market. This has put the Indian law firms in a growth trajectory and they are benefiting strongly from the surge in mergers and acquisitions (M & A) in the last few months. India’s biggest law firm [...] Continue Reading »
As per the reference to the news appearing in the sources titled as Sun Pharma to buy Stan Chart’s Mumbai Tower for Rs. 280 crore. A clarification has come up by the Sun Pharmaceutical Industries that they have get into a initial understanding with Standard Chartered Bank for buying of the property referred into the [...] Continue Reading »
Two persons familiar with the development, informed that the drug maker company Sun Pharamacuitals will buy the official building in Mumbai’s Goregaon suburb from Standard Chartered Bank for Rs 280 crore. The building is named as Standard Chartered Tower which consists of ground plus six upper floors and has total built up area of 2.20 [...] Continue Reading »
